Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily.
暂无分享,去创建一个
J. Schneider | J. Schulz | M. Andrassy | E. Schleicher | B. Neundörfer | M. Schwaninger | S. Schiekofer | A. Schmidt | H. Tritschler | D. Stern | P. Nawroth | A. Bierhaus | B. Liliensiek | P. Humpert | M. Morcos | M. Kasper | B. Arnold | D. Heuss | K. Haslbeck | H. Haering | T. Dehmer | S. Dierl | A. Sayed | Jochen Huber | B. Neundörfer
[1] M. Cotter,et al. Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents. , 1995, The Journal of clinical investigation.
[2] J. Tooke,et al. Diabetic Neuropathy and the Microcirculation , 1995, Diabetic medicine : a journal of the British Diabetic Association.
[3] A. Cerami,et al. Nonenzymatic glycosylation of peripheral nerve protein in diabetes mellitus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[4] A. Vinik,et al. Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. , 2001, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
[5] M. Hanefeld,et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. , 1999, Diabetes care.
[6] A. Schmidt,et al. Characterization and Functional Analysis of the Promoter of RAGE, the Receptor for Advanced Glycation End Products* , 1997, The Journal of Biological Chemistry.
[7] A. Schmidt,et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.
[8] P. O'Brien,et al. The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid , 2003 .
[9] C. Stucky,et al. Isolectin B4-Positive and -Negative Nociceptors Are Functionally Distinct , 1999, The Journal of Neuroscience.
[10] H. Tritschler,et al. Lipoic Acid Improves Nerve Blood Flow, Reduces Oxidative Stress, and Improves Distal Nerve Conduction in Experimental Diabetic Neuropathy , 1995, Diabetes Care.
[11] Xi Chen,et al. RAGE potentiates Aβ‐induced perturbation of neuronal function in transgenic mice , 2004, The EMBO journal.
[12] M. Brownstein,et al. A role for ASIC3 in the modulation of high-intensity pain stimuli , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[13] F. Holsboer,et al. High Constitutive NFk B Activity Mediates Resistance to Oxidative Stress in Neuronal Cells , 1998 .
[14] G. Grunberger,et al. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat , 2001, Diabetologia.
[15] P. Fernyhough,et al. Neurotrophins and peripheral neuropathy. , 1996, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[16] M. Andrassy,et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. , 2001, Diabetes.
[17] E. Schleicher,et al. Nε-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies , 2002, Acta Neuropathologica.
[18] E. Feldman,et al. Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. , 1999, European journal of pharmacology.
[19] E. Schleicher,et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. , 2004, The Journal of clinical investigation.
[20] D. Horrobin,et al. A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy , 1998, Diabetologia.
[21] P. Low,et al. Pro- and Anti-inflammatory Cytokine Gene Expression in Rat Sciatic Nerve Chronic Constriction Injury Model of Neuropathic Pain , 2001, Experimental Neurology.
[22] Mark P. Mattson,et al. NF-κB in neuronal plasticity and neurodegenerative disorders , 2001 .
[23] M. Brownlee. Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.
[24] J. Isner,et al. Reversal of experimental diabetic neuropathy by VEGF gene transfer. , 2001, The Journal of clinical investigation.
[25] J. Schröder. Hereditary Motor and Sensory Neuropathies , 2001 .
[26] Y. Kaneda,et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage , 2000, Nature.
[27] T. Wirth,et al. Distinct NF-κB/Rel transcription factors are responsible for tissue-specific and inducible gene activation , 1993, Nature.
[28] G. Curran,et al. Increased permeability across the blood-nerve barrier of albumin glycated in vitro and in vivo from patients with diabetic polyneuropathy. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Macko,et al. Thrombomodulin deficiency in human diabetic nerve microvasculature. , 2002, Diabetes.
[30] A. Vinik,et al. Diabetic neuropathies , 2000, Diabetologia.
[31] Michael Stumvoll,et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. , 2003, Diabetes.
[32] A. Vincent,et al. Oxidative Stress and Programmed Cell Death in Diabetic Neuropathy , 2002, Annals of the New York Academy of Sciences.
[33] B. Díaz-Esnal,et al. S‐100 proteins in the human peripheral nervous system , 2003, Microscopy research and technique.
[34] D. Zochodne,et al. Diabetic peripheral nerves are susceptible to multifocal ischemic damage from endothelin , 1999, Brain Research.
[35] L. Lue,et al. Involvement of Microglial Receptor for Advanced Glycation Endproducts (RAGE) in Alzheimer's Disease: Identification of a Cellular Activation Mechanism , 2001, Experimental Neurology.
[36] E. Schleicher,et al. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. , 1997, The Journal of clinical investigation.
[37] A. Boulton. Lowering the risk of neuropathy, foot ulcers and amputations , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[38] Consensus statement: Report and recommendations of the San Antonio conference on diabetic neuropathy. American Diabetes Association American Academy of Neurology. , 1988, Diabetes care.
[39] P. O'Brien,et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. , 2003, Diabetes care.
[40] M. Crow,et al. Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion. , 2001, Diabetes.
[41] A. Dickenson,et al. Nerve injury alters the effects of interleukin-6 on nociceptive transmission in peripheral afferents. , 2004, European journal of pharmacology.
[42] T. Kislinger,et al. N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression* , 1999, The Journal of Biological Chemistry.
[43] V. D’Agati,et al. Receptor for Advanced Glycation End Products Mediates Inflammation and Enhanced Expression of Tissue Factor in Vasculature of Diabetic Apolipoprotein E–Null Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[44] A. Lastra,et al. Unilateral hot plate test: a simple and sensitive method for detecting central and peripheral hyperalgesia in mice , 2002, Journal of Neuroscience Methods.
[45] B. Isermann,et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB , 1999, Diabetologia.
[46] M. Karin,et al. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. , 1997, The New England journal of medicine.
[47] J. Levine,et al. Protein kinase C inhibitors decrease hyperalgesia and C-fiber hyperexcitability in the streptozotocin-diabetic rat. , 1994, Journal of neurophysiology.
[48] Rainer Constien,et al. Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line , 2001, Genesis.
[49] T. Luther,et al. Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells , 1997, Diabetes.
[50] K. Usadel,et al. The effect of alpha-lipoic acid on the neurovascular reflex arc in patients with diabetic neuropathy assessed by capillary microscopy. , 1999, Microvascular research.
[51] S. Yagihashi,et al. Localization in human diabetic peripheral nerve of Nɛ-carboxymethyllysine-protein adducts, an advanced glycation endproduct , 1997, Diabetologia.